WHC is still in active development. Read this to understand our approach.
depiction of BCQZXOMGPXTTIC-UHFFFAOYSA-N.svg
tripsit

halothane

Verificar en tripsit

isomerdesign

Halothane

Verificar en isomerdesign

pubchem

Halothane

Verificar en pubchem

drugmap

Halothane

Verificar en drugmap

wiki

Halothane

Verificar en wiki

Data

InChI: InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H

Sinónimos: Tox21_111033_1, Narcotann ne-spofa,Halotano [INN-Spanish], Fluktan,Ftorotan, Alotano [DCIT],Narcotan,HALOTHANE [USP MONOGRAPH],CCG-213438, Halotano,Halotan,Epitope ID:150925,Fluktan,NCGC00258404-01, Ftorotan, Narcotane,Rhodialothan,Ethane, 1-bromo-1-chloro-2,2,2-trifluoro-,Halothane [Anaesthetics, volatile],AKOS006227959,1,1-Trifluoro-2-chloro-2-bromoethane,Bromochlorotrifluoroethane,J-008834,Halothane, United States Pharmacopeia (USP) Reference Standard, Bromochlorotrifluoroethane,2,2-Trifluoro-1-chloro-1-bromoethane,NSC143490,BRN 1736947,1-bromo-1-chloro-2,2,2-trifluorethane,Halothan,HSDB 6753,Halothanum [INN-Latin],NCGC00090868-01, Halothane [INN:BAN:JAN],Alotano [DCIT],WLN: GYEXFFF,HALOTHANE [WHO-DD],Tox21_111033,CAS-151-67-7, Halothanum [INN-Latin],HMS3885H08,Narcotann ne-spofa, Ftorotan [Russian],Tox21_200850, Narcotann NE-spofa [Russian],NCGC00090868-06, Halotan,DTXSID4025371,NSC 143490,HALOTHANE [MART.],NCGC00090868-02,Halothane [USP:INN:BAN:JAN],CCRIS 6244,HALOTHANE [ORANGE BOOK],Halothane (JP17/USP/INN),HALOTHANE [EP MONOGRAPH],HALOTHANUM [WHO-IP LATIN], Rhodialothan,(.+/-.))-Halothane,halothane,2-Bromo-2-chloro-1,1-trifluoroethane,HALOTHANE [WHO-IP],(+/-)-2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE,Halan, Fluothane (TN),(+-)-2-Bromo-2-chloro-1,1,1-trifluoroethane,ETHANE, 2-BROMO-2-CHLORO-1,1,1-TRIFLUORO-,(+/-)-,CS-4523,HALOTHANE [EP IMPURITY], Halotano [INN-Spanish], Anestan,FT-0626853,1,1-Trifluoro-2-bromo-2-chloroethane, Ftuorotan, Halothanum,SBI-0206928.P001,1-Bromo-1-chloro-2,2,2-trifluoroethane, 99%, (+-)-2-Bromo-2-chloro-1,1,1-trifluoroethane,Narcotann NE-spofa [Russian],EINECS 205-796-5,HALOTHANE [MI],NCGC00090868-03,C07515,Phthorothanum,HALOTHANE [HSDB],SCHEMBL25588, 2-Brom-2-chlor-1,1,1-trifluorethan,HALOTHANE [VANDF],DB-043111,D00542,Ftorotan [Russian],Narcotane,Halon 2311,Halotano, Halan,Q32921,NSC760138,NSC-760138,HALOTHANE [INN],BDBM50112212, CF3CHClBr,1,1,1-Trifluoro-2-bromo-2-chloroethane,Halothane,2-Bromo-2-chloro-1,1,1-trifluoroethane, >=99%,AB01563314_01,CF3CHClBr,HY-B1010,Halsan,2-Brom-2-chlor-1,1,1-trifluorethan, 1-Bromo-1-chloro-2,2,2-trifluoroethane,Anestan,CHEBI:5615,UQT9G45D1P,Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-, (+-)-,Freon 123B1, Halothane [Anaesthetics, volatile], 2,2,2-Trifluoro-1-chloro-1-bromoethane,Ftuorotan, Bromchlortrifluoraethanum,Chalothane, Halothane (JP15/USP/INN),HMS2094K17,Fluothane,NCGC00090868-05,H11280, 1,1,1-Trifluoro-2-chloro-2-bromoethane,Ethane,1,1-trifluoro-,Pharmakon1600-01505434,Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-,DSSTox_GSID_25371,NSC-143490,2,2,2-Trifluoro-1-chloro-1-bromoethane,Narkotan,DSSTox_RID_77767,HALOTHANE [GREEN BOOK],Fluorotane,CHEMBL931, 2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE, Fluorotane,UNII-UQT9G45D1P, Freon 123B1,151-67-7, Halothan,EN300-90288, Halsan,1,1,1-Trifluoro-2-chloro-2-bromoethane, Narkotan,Alotano,DB01159,Z1201617125, Phthorothanum,DSSTox_CID_5371, 1,1,1-Trifluoro-2-bromo-2-chloroethane, Fluothane, Chalothane,HALOTHANE [JAN],Ethane, bromochlorotrifluoro-,Fluothane (TN),SR-05000001969,2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE,2-Bromo-2-chloro-1,1,1-trifluoroethane, >=99.0% (GC),Halothanum,Bromchlortrifluoraethanum,SR-05000001969-1, Narcotan,s4570,BCQZXOMGPXTTIC-UHFFFAOYSA-,GTPL2401,MFCD00009602,1-Bromo-1-chloro-2,2,2-trifluoroethane

Estimated data

Solubilidad: -1.875 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 59.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.